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Reorganization of skin during wound healing, in£am-
matory disorders, or cancer growth is the result of ex-
pression changes of multiple genes associated with
tissue morphogenesis. We wanted to identify proteins
involved in skin remodeling and select those that may
be targeted for agonistic or antagonist therapeutic ap-
proaches in various disease processes. Full-thickness
human skin was grafted to severe combined immuno-
de¢cient mice and injected intradermally with 38 dif-
ferent adenoviral vectors inserted with 37 di¡erent
genes coding for growth factors, cytokines, proteolytic
enzymes and their inhibitors, adhesion receptors, onco-
genes, and tumor suppressor genes. Responses were
characterized for in¢ltration of in£ammatory cells, vas-
cular density, matrix formation, ¢broblast-like cell pro-
liferation, and epidermal hyperplasia. Of the 17 growth
factor vectors, 16 induced histological changes in hu-
man skin. Members of the VEGF and angiopoietin fa-
milies induced neovascularization. PDGFs and TGF-bs
stimulated connective tissue formation, and the chemo-
kines IL-8 and MCP-1 attracted in£ammatory neutro-
phils and monocytes, respectively. The serine protease
uPA induced a vascular response similar to that of
VEGF. Vectors with adhesion receptors, oncogenes and
tumor suppressor genes had, with few exceptions, little
e¡ects on skin architecture. The overall results suggest
that adenoviral vectors can e¡ectively remodel the
architecture of human skin for studies in morphogen-
esis, in£ammatory skin disorders, wound healing, and
cancer development. Keywords: adenovirus/human skin
graft/growth factor/skin remodelling. J Invest Dermatol
120:683 ^692, 2003
H
uman skin has a unique architecture and is very
di¡erent from skin of laboratory animals, includ-
ing mice. It has a multilayered epidermis with ker-
atinocytes, melanocytes, and Langerhans cells, and
a thick, well-vascularized dermis. By comparison,
the mouse skin has only 3^4 keratinocyte layers and a thin der-
mis. Studies of tissue reorganization in wound healing, cancer
and in£ammation are di⁄cult to compare between mice and
humans. We therefore developed a human skin/SCID mouse
chimera model in which full-thickness human skin is grafted to
immunode¢cient mice (Juhasz et al, 1993). The human epidermis
remains unchanged, whereas the dermis becomes in¢ltrated by
murine blood vessels and some murine in£ammatory cells (Yan
et al, 1993).The human skin graft maintains its unique architecture
throughout the lifetime of the animal, and it has success-
fully been used for studies of wound healing (Juhasz et al, 1993;
Sylvester et al, 2000), in£ammation (Oka et al, 2000), carcino-
genesis (Atillasoy et al, 1998), tumor growth and metastasis (Sauter
et al, 1999a). Increasingly, this model is being used for pre-clinical
studies to predict the outcome in human skin following thera-
peutic intervention.
Pathological changes in skin are associated with profound
changes in expression of a variety of genes that are associated
with skin morphogenesis. Correlative studies testing for protein
or mRNA expression have provided information of potentially
important agents in skin remodeling processes. Injection of
recombinant proteins into skin or their topical application to
wounds has provided preliminary information on their potential
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for wound repair and skin remodeling. However, recombinant
proteins are rapidly degraded and need frequent reapplications to
have lasting e¡ects. Therefore, gene therapy approaches are attrac-
tive alternatives for studies of protein functions. Adenoviral vec-
tors readily infect most human skin cells and are widely accepted
for e⁄cient gene transduction (Setoguchi et al, 1994). Adenovirus-
mediated gene transfer results in protein expression within 24 h
with a maximum at 72 h (Berking et al, 2001a, 2001b; Nesbit et al,
2001a; Nesbit et al, 2001b). Depending on the proliferation of
transduced cells and a potential immune response, forced gene
expression in human skin grafts may last up to 3 weeks.
Wound healing, cutaneous in£ammatory disorders such as
psoriasis and scleroderma, or skin cancer formation are complex
processes that are di⁄cult to dissect into gene expression changes
that cause tissue remodeling. However, investigations of these
conditions are often hampered by the lack of adequate animal
models, where single parameters can be experimentally modi¢ed.
In this study, we have transduced human skin grafted to SCID
mice with adenoviral vectors without prior wounding.We chose
human skin for injection of adenoviral vectors instead of mouse
skin because the mouse dermis is generally too thin for even
small quantities of £uid requiring subdermal or subcutaneous de-
position of the vector(s). The proteins under study were selected
for their potential involvement in skin morphogenesis, wound
healing, in£ammation, and cancer. The full-thickness well-healed
skin grafts were injected with adenoviral vectors for growth
factors, chemokines, proteolytic enzymes, enzyme inhibitors,
adhesion receptors, proto-oncogenes, tumor suppressor genes,
several antagonists to growth factors, growth factor receptors or
a receptor for a protease.The resulting remodeling of human skin
demonstrates the utility of the presented approach for further
in-depth studies of a variety of dermatological conditions.
In£ammation, neovascularization, and connective tissue forma-
tion could be induced. These pathobiological reaction patterns
are hallmarks of skin diseases such as psoriasis and scleroderma.
The endogenous overexpression of genes produced strong
responses.
MATERIALS AND METHODS
Adenovirus preparation Serotype 5, replication defective adenovirus
vectors were used in this study. The backbone of adenoviruses had either
E1 or E1 and E3 deleted regions and all the transgenes were driven by the
cytomegalyvirus promoter. The parental adenoviruses include pMJ17 (E1
deleted), d17001, Adeasy-1 and in340 (E1 and E3 deleted) viruses. The
viruses included in the study are listed in Table 1. All viruses were
prepared from 293 cells, puri¢ed by double CsCl density centrifugation
(Graham and Prevec, 1995) and stored in 50% glycerol containing 10 mM
Tris, pH 8.0, 0.1 mM EDTA, and 0.1% BSA at ^ 801C. Virus titers were
determined by measuring absorbance at 260 nm and by plaque assay as
described before (Satyamoorthy, et al, 1997). Virus preparations were
dialyzed extensively against phosphate bu¡ered saline before injection
into animals. Expressions of all transgenes were measured as previously
described (see references in Table 1) byWestern analysis, ELISA, RIA, or
Northern analysis wherever applicable. All animal experiments were
approved by the IACUC (institutional review board for all animal
experiments).
Human skin grafting C.B.-17 SCID mice between 4 and 6 wk of age
were used for grafting of human foreskins from newborns (Atillasoy et al,
1998; Berking et al, 2001a, b). The 1.5^2 cm2 full-thickness skin specimens
were placed into size-matched wound beds on the dorsal torso of the mice.
Each mouse received a separate graft, which was allowed to heal for 4^6
wk prior to injection of adenoviral vectors.
Gene transfer Human skin grafts were injected with 100 mL of virus
suspension containing 5108 plaque forming units (pfu) in phosphate-
bu¡ered saline (PBS). The viruses were injected intradermally with
Hamilton gas-light syringes with 30-gauge needles (Reno, NY). Four to
15 grafts were injected with the same vector. For each set of 5 viruses one
control lacZ group was included. Intradermal injection was con¢rmed by
presence of an epidermal elevation. The area of injection was marked with
indelible ink. Starting three d following injection, mice were sacri¢ced and
grafts were harvested for histological analysis.
Tissue processing and histological evaluation The human skin grafts
were dissected free from surrounding murine tissue and bisected
perpendicular to the long axis of the graft. The grafts were ¢xed
overnight in 10% neutral bu¡ered formalin at 41C, and half were para⁄n
embedded for histological assessment. The other half of the grafts were
cryopreserved after dehydration in 20% sucrose overnight at 41C.
Serial sections (5 mm) from each of the formalin-¢xed, para⁄n-
embedded grafts were cut onto slides and stained with hematoxylin and
eosin (H&E). The degree of acute in£ammatory response, vascular
response, connective tissue and epidermal reaction to the adenovirus-
mediated transgenes was assessed independently by 2 observers (C.J.G.
and J.L.). Uniform staining of sections was evaluated at low magni¢cation
(X100). Individual counts for in£ammatory cells such as granulocytes,
lymphocytes and monocytes, vessels, and ¢broblasts were then taken at
high magni¢cation (X400). Counts were quanti¢ed as the number of
structures/mm2 (1 high power ¢eld¼ 0.0496 mm2). Each count was
performed independently on ¢ve representative high power ¢elds by the
two investigators. For evaluation of collagen in the skin tissues, Masson’s
trichrome stain was performed on formalin-¢xed para⁄n-embedded
sections according to standard protocols. Collagen deposition was
quanti¢ed using Image-ProPPlus analyzing software (Media Cybernetics,
L.p., Silver Spring, MD).With the help of this image analyzing software,
the collagen-speci¢c color densitometric measurements were converted to
optical density. Epidermal hyperplasia was evaluated by determining the
number of papillae/mm epidermal surface and measuring epidermal
thickness. Changes in skin were scored negative if both observers agreed
the e¡ect was below a prospectively set threshold for each evaluation
criteria using skin injected with the lacZ as GFP adenoviral vectors and
PBS (phosphate-bu¡ered saline) as controls. To distinguish between
human and mouse cells, sections were stained with Hoechst dye that
provides characteristic staining for human vs. mouse cells (Atillasoy et al,
1998; Berking et al, 2001a, 2001b). Statistical comparisons between test
group and control groups, lacZ/Ad5 or GFP/Ad5-injected skin, were done
by Student’s t test.
For b-Galactosidase histochemistry, cryosections on slides were ¢xed in
0.5% glutaraldehyde for 10 min, followed by rinsing twice in 1mM MgCl2
for 10 min each. The slides were then incubated for 1 h in the dark at 371C
in 1mM MgCl2, 20XKCl in PBS solution at pH 7.4, and b-galactosidase (5-
bromo-4-chloro-3-indolyl b-galactopyranoside) at a ¢nal concentration of
1 mg/ml. They were then washed 3 times in tap water and coverslipped
with mounting medium for microscopic evaluation.
Immunohistochemistry Immunohistochemistry was performed on
serial sections using an avidin-biotin-peroxidase system kit (Vector
Laboratories, Burlingame, CA) and 3,30 -diaminobenzidine tetrahydro-
chloride (Sigma) or 3-amino-9-ethylcarbazole (Vector) as chromogens.
Antigens in the formalin-¢xed tissues were retrieved by trypsin digestion
at 371C or microwave heat treatment in citrate bu¡er. Cryostat sections cut
between 6 and 8 mm on a slide were air-dried and ¢xed in ice-cold acetone
for 10 min prior to incubation with the primary antibodies in a humidi¢ed
chamber at 41C overnight or at room temperature for 1^2 h. Non-speci¢c
binding was blocked with 10% normal horse or 10% normal goat serum.
Primary monoclonal antibodies used in this study were: mouse
anticollagen type IV, antimurine PECAM-1, and antismooth muscle actin
antibodies. A mouse IgG1 isotype antibody (P3) was used as negative
control for each staining. Between each incubation step, slides were rinsed
twice in PBS for 3^5 min. A biotin-labeled antimouse secondary antibody
was applied for 30 min at room temperature followed by incubation with a
preformed avidin-biotinylated enzyme complex for 30 min. After color
development by adding the chromogen and counterstaining with Mayer’s
hematoxylin (Sigma), sections were mounted and evaluated under a light
microscope.
RESULTS
Thirty-eight adenoviral vectors of di¡erent gene groups were
prepared for injection into human skin grafts. The largest group
of human proteins was represented by growth factors and cyto-
kines followed by adhesion receptors, proteolytic enzymes, their
inhibitors, the antisense uPA receptor, and oncogenes and tumor
suppressor genes (Table 1). Intradermal injection of the 100 mL
virus suspension created an elevation (papule) that disappeared
within 1^2 days. Staining for b-galactosidase 3 days after injec-
tion of the lacZ control vector (lacZ/Ad5) revealed strong positivity
684 GRUSS ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
in the dermis, whereas the epidermal cells were not stained (not
shown). A mild in£ammatory in¢ltrate containing monocytes/
macrophages and neutrophils was invariably seen 3 d after adeno-
virus injection regardless of the type of the vector, which was not
seen after the injection of PBS. Nine of the 17 growth factors and
cytokines induced macroscopic changes in the human skin that
were ¢rst visible 48^72 h after injection of the adenoviral vectors.
The clinical responses were characterized as swelling (PDGF-A,
PDGF-B, VEGF-D, TGF-b1, TGF-b3), erythema (VEGF, VEGF-
C) and/or edema (VEGF, MCP-1, IL-8) and lasted for one wk
and up to 8 wk (Table 2). Histological changes peaked between
d 3 and 7 after injection and lasted for a maximum of 6 wk. Due
to the episomal nature of adenovirus-mediated gene expression,
human proteins could be detected up to 2 wk (Nesbit et al,
2001b). After 10^14 d, histological responses began to decrease.
The longest lasting responses were seen for PDGF-B and VEGF.
Most likely,TGF-b1 also induced long-lasting changes. However,
injection of 5108 pfu TGF-b1/Ad5, lead to the death of ani-
mals on d 10 (Berking et al, 2001b). The adenoviral vector for
the growth factor pleiotrophin did not induce any changes
(Satyamoorthy et al, 2000). In addition, all adhesion receptors,
N-cadherin, E-cadherin, b3 integrin, a2 integrin, a5 integrin,
MUC18 (Table 1) did not induce any changes in skin with the
exception of a moderate angiogenic response by Mel-CAM. Of
the oncogenes and tumor suppressor genes listed inTable 1, only
p53 and c-myc induced mild hyperplasia and thrombosis.
Table1. Adenoviral Vectors For Over-Expression of Proteases, Inhibitors, Adhesion Receptors, Oncogenes,Tumor Suppressor
Genes, and Miscellaneous Human Genesa
Gene group Abbreviation Adenovirus Description Reference (source)c
Growth factors and cytokinesb
Basic ¢broblast growth factor (18 kDa) bFGF dl7001 E1, E3, Ad5 Nesbit et al, 1999, Berking et al, 2001a
Basic ¢broblast growth factor (18, 22, 23, 24 kDa) bFGF(l) dl7001 E1, E3, Ad5 Nesbit et al, 1999, Berking et al, 2001a
Platelet-derived growth factor A PDGF-A dl7001 E1, E3, Ad5 (Herlyn Lab)
Platelet-derived growth factor B PDGF-B dl7001 E1, E3, Ad5 Liechty et al, 1999; Nesbit et al, 2001a
Insulin-like growth factor-1 IGF-1 AdEasy-1 E1, E3, Ad5 Satyamoorthy et al, 2001a, b
Monocyte chemoattractant protein-1 MCP-1 dl7001 E1, E3, Ad5 Nesbit et al, 2001b
Interleukin-8 IL-8 dl7001 E1, E3, Ad5 Oka et al, 1999
Vascular endothelial cell growth factor-121 VEGF dl7001 E1, E3, Ad5 Herlyn Lab
Vascular endothelial cell growth factor C VEGF-C AdEasy-1 E1, E3, Ad5 (Herlyn/Detmar Labs.)
Vascular endothelial cell growth factor D VEGF-D AdEasy-1 E1, E3, Ad5 (Herlyn/Detmar Labs.)
Pleiotrophind Pleiotrophin dl7001 E1, E3, Ad5 Satyamoorthy et al, 2000
Transforming growth factor beta-1, active porcine TGF-b1 E1, E3, Ad5 Lee et al., 1998, Berking et al, 2001a
Transforming growth factor beta-3 TGF-b3 AdEasy-1 E1, E3, Ad5 (Cromblehome Lab.)
Hepatocyte growth factor/Scatter factor HGF/SF dl7001 E1, E3, Ad5 Phaneuf et al, 2000
Angiopoietin-1 Ang-1 in340 E1, E3, Ad5 Regeneron
Endothelin-3 ET-3 AdEasy-1 E1, E3, Ad5 (Herlyn Lab)
Stem cell factor SCF AdEasy-1 E1, E3, Ad5 (Herlyn Lab)
Proteolytic enzymes, inhibitors, and antagonists
Matrix metalloproteinase-9 MMP-9 dl7001 E1, E3-Ad5 (Herlyn Lab.)
Urokinase type plasminogen activator uPA pJM17 E1, Ad5 Nagai et al, 1999
Plasminogen activator inhibitor-1 PAI-1 pJM17 E1, Ad5 Carmeliet et al, 1997
Antisense urokinase type plasminogen activator receptor ASuPAR pJM17 E1, Ad5 Mohan et al, 1999
Tissue inhibitor of matrix metalloproteinase-1 TIMP-1 pJM17 E1, Ad5 Baker et al, 1996
Adhesion receptors
N-Cadherind N-Cadherin dl7001 E1, E3, Ad5 Li et al, 2001
E-Cadherind E-Cadherin dl7001 E1, E3, Ad5 Hsu et al, 2000
b3-Integrind b3 dl7001 E1, E3, Ad5 Hsu et al, 1998
a2 Integrind a2 dl7001 E1, E3, Ad5 Nesbit et al, 2001a
a5 Integrind a5 dl7001 E1, E3, Ad5 Nesbit et al, 2001a
Melanoma cell adhesion molecule (MUC18, CD146, S-Endo-1)e Mel-CAM AdEasy-1 E1, E3, Ad5 Satyamoorthy et al, 2001b
Oncogenes, tumor suppressor genes and others
Human papillomavirus type 16-E6 oncogened HPV16-E6 dl7001 E1, E3, Ad5 Prabhu et al, 1998
Human papillomavirus type 16-E7 oncogened HPV16-E7 dl7001 E1, E3, Ad5 (Eck Lab.)
Tumor suppressor protein p16INK4A
d
p16INK4A dl7001 E1, E3, Ad5 Mitra et al, 1999
Tumor suppressor protein p21Waf1/cip1
d
p21Waf1/cip1 pJM17 E1, Ad5 Prabhu et al, 1996
Tumor suppressor protein p53f p53 pJM17 E1, Ad5 Blagosklonny et al, 1996
Antisense cyclin D1 (AS)d Cyclin D1 (AS) dl7001 E1, E3, Ad5 Sauter et al, 1999b
Cellular homologue of avian myelocytomatosis virus oncogenef c-myc pMJ17 E1, Ad5 Mitchell et al, 1999
Fibroblast growth factor binding protein FGF-BP dl7001 E1, E3, Ad5 Sauter et al, 2001
Control vectors
LacZ LacZ dl7001 E1, E3, Ad5 Satyamoorthy et al, 1997
Green £uorescence proteind GFP dl7001 E1, E3, Ad5 De Martin et al, 1997
a CMV promoter was used for all adenoviral constructs.
bAll genes were of human origin unless otherwise indicated.
cReferences refer to characterization of the adenoviral vector.
dReactivity in human skin was similar to the LacZ/Ad5 vector. Therefore, results in ¢gures are not listed.
eInduction of angiogenesis at 195712 vessels/mm2.
fInduction of hyperplasia at 0.17 mm/mm2. c-myc/Ad5 also induced thrombosin at 75 vessels/mm2.
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Growth factors induced new blood vessels, but extent and dy-
namics of induction varied. bFGF did not induce blood vessels
within 3 d (Fig 1A), but it showed strong angiogenic activities
after three injections at weekly intervals (Berking et al, 2001a).
Both PDGF-A and PDGF-B were angiogenic, as were SCF and
ET-3, whereas neither IGF-1 nor HGF/SF induced new blood
vessels. Whereas the peak induction of stroma formation by
PDGF-B was within 3 to d after injection of the adenoviral vec-
tor (Table 2), the angiogenic response was delayed by several days
apparently due to the PDGF-B-mediated stimulation of VEGF
(Nesbit et al, 2001b). VEGF is the strongest angiogenic growth
factor inducing an intense erythema within 3 d (Fig 2B) when
compared to LacZ/Ad injected skin (Fig 2A). The skin was se-
verely swollen for two wk (Fig 2C,D), and the edema subsided
by day 28 (Fig 2E). Its appearance changed by 60 d to a pink
glazed color (Fig 2F). Histologically,VEGF-induced vessels were
large and dilate with the endothelial cells on day 3 being swollen
and bulging into the lumen (Fig 2G). The dermis developed ede-
ma, and minimal hypoplasia of the epidermis was seen. Endothe-
lial cell proliferation continued for at least 4 wk. At that time, the
vascular spaces decreased in size. Injection of LacZ/Ad5 or
GFP/Ad5 induced no increase in blood vessels and resulted in
only mild dermal edema with mild mixed in£ammatory in¢l-
trate (Fig 2H). At 60 d theVEGF-injected grafts showed a reduc-
tion in the number of vessels with a thinning of the epidermis
and loss of ridge structures indicative of scarring. The other
members of the VEGF family tested,VEGF-C and VEGF-D had
similar but milder e¡ects on vessel formation. Ang-1 and TGF-b1
also showed moderate induction (Berking et al, 2001b), whereas
TGF-b3 and the chemokines IL-8 and MCP-1 showed little
e¡ects on vessel numbers when compared to control vectors.
Indirect e¡ects may lead to vessel formation by factors that are
not angiogenic on their own. For example, MCP-1 expressed by
melanoma cells attracts monocytes/macrophages that can secrete
angiogenic cytokines such as TNF-a (Nesbit et al, 2001a).
The serine protease uPA induced strong vessel formation (Fig
3B,C), which was similar toVEGF when expressed as number of
vessels/mm2. However, the vessels were smaller and there was no
erythema visible in the skin. Few vessels are seen when LacZ/Ad5
was injected into the dermis (Fig 3D). Neither PAI-1, an anti-
sense constructs for the uPA receptor, MMP-9, or TIMP showed
angiogenic activities.
Dermal stroma reactions were characterized by proliferation of
nonin£ammatory cells such as ¢broblasts, smooth muscle cells
and pericytes (Fig 1B). bFGF, PDGF-A, PDGF-B, and IGF-1 all
stimulated stromal cells, whereas SCF, ET-3, HGF/SF, VEGF,
VEGF-C, VEGF-D, and Ang-1 showed little or no induction.
Strong inducers of ¢broblastic cells were both TGF-b1 and TGF-
b3, whereas the chemokines IL-8 and MCP-1 showed no activ-
ities. None of the two proteolytic enzymes, their inhibitors or
the antisense uPARvector induced stromal cells.
Induction of matrix formation coincided with stimulation
of nonin£ammatory cells by growth factors and cytokines
(Fig 1C). Matrix deposition, measured after trichrome staining
for all collagens, was strongest for those vectors that stimulated
nonin£ammatory cells. Stimulatory activities had bFGF, PDGF-
A, PDGF-B, IGF-I, VEGF-D, and TGF-b1 and TGF-b3. Several
growth factors that were angiogenic did not induce a signi¢cant
connective tissue reaction, including VEGF, VEGF-C, SCF or
ET-3. Similarly, uPA that was highly angiogenic did not induce
a signi¢cant proliferation of ¢broblasts nor did it induce matrix
formation. An example for induction of matrix is given for IGF-1
Table 2. Response in human skin grafts to adenoviral vector-mediated over-expression of growth factors, chemokines and
proteolytic enzymes and their inhibitors.
Adenoviral vectora No. of human skin graftsb Clinical responsec Histological responsed
Peak Duration
bFGF 12 NRe 14 42
PDGF-A 4 7 3^5 28
PDGF-B 15 21 3^5 42
IGF-1 6 NR 3^7 21
SCF 8 NR 3^7 21
ET-3 8 NR 3^7 21
HGF/SF 4 NR 3 3
VEGF 10 42 3^5 60
VEGF-C 4 7 3^7 7f
VEGF-D 4 14 3^7 7f
Ang-1 4 NR 3^7 7f
TGF-b1 12 410
g 3^7 10g
TGF-b3 6 7 3^7 14
IL-8 8 14 3 8-14
MCP-1 10 10 3 8-14
uPA 8 NR 3^7 7f
PA1-1 4 NR 3^7 7f
ASuPAR 4 NR 3^7 7f
MMP-9 4 NR 3^7 7f
TIMP-1 4 NR 3h 3
lacZi 15 NR 3h 3
GFPi 15 NR 3h 3
a5 X 108 pfu in 100 ml PBS were injected intradermally.
bEach human skin graft was cut between 1 and 2 cm2 and was injected with a single vector. At the end of each experiment, mice were sacri¢ced and the grafts were
examined histologically and immunohistologically.
cDays when changes in color, swelling, consistency were noted.
dDays of histological changes described in Figure
eNR, no visible response.
fMaximal observation time was day 7.
gMaximal observation time because animals died between 10 and 14 days after injection even if 10-fold lower concentration of virus was injected.
hResponse was restricted to mild and transient in£ammatory cell in¢ltrate.
iNegative controls.
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(Fig 3E) which shows strong collagen induction when compared
to the lacZ control group (Fig 3A).
The in£ammatory response was correlated with the degree of
in¢ltration of in£ammatory cells such as neutrophils and mono-
cytic cells (Fig 4A). Growth factors that induced angiogenesis
and stimulated ¢broblastic cells to produce increased collagen
were generally not inducing in£ammatory cells. Growth factors
that did not activate in£ammation included bFGF, PDGF-A,
PDGF-B, IGF-1, ET-3, HGF/SF, VEGF, VEGF-C, VEGF-D and
TGF-b3, whereas SCF, Ang-1 and TGF-B1, not only induced
increased in¢ltration of in£ammatory cells but also vessel
thrombosis with concomitant necrosis of the surrounding area
(Fig 4B).
The cytokines with chemoattractive activity for either mono-
cytes/macrophages (MCP-1) or neutrophils (IL-8) were the stron-
gest inducers of in£ammatory cells (Oka et al, 2000; Nesbit et al,
2001a). Examples of neutrophil in¢ltration after IL-8 overexpres-
sion are given in Fig 3F, and for monocyte in¢ltration after
MCP-1 overexpression in Fig 3G. A similarly strong reaction
was induced by the serine protease uPA, its inhibitor, PAI-1.
Thrombosis with a mild in£ammatory cell in¢ltrate was
observed with the antisense vector for the uPA receptor,
Figure1. Induction of vessels, stimulation of nonin£ammatory cells, and production of collagen in human skin grafted to SCID mice after
injection of replication-de¢cient adenoviral vectors coding for growth factors, cytokines, proteolytic enzymes and their inhibitors.The ade-
noviral vectors were injected intradermally at 5108 pfu/100 mL, and the grafts were harvested 3 days later for histological and immunohistological analyzes.
All vectors from Table 1 not listed here were nonreactive. (A) Vessel formation was initially determined on H&E-stained section and was con¢rmed by
staining with anticollagen IVantibodies (not shown), and, in part, with antihuman and antimouse PECAM-1 (CD31). Adenoviral vectors for lacZ and GFP
served as negative controls. Bars indicate number of vessels7SD counted on ¢ve high power ¢elds of histological sections through the center of injected
grafts. All values4175 vessels/mm2 are signi¢cant (po0.05). (B). Presence of cells other than in£ammatory cells in human skin grafts 3 days after adenoviral
vector injection. Cells include ¢broblast-like cells, smooth muscle cells, pericytes and single endothelial cells and their precursors. Results are expressed as
number of nonin£ammatory cells/mm27SD.Values41650/mm2 are signi¢cantly di¡erent from controls (po0.05). (C). Collagen in skin grafts was stained
withTrichrome. Results are expressed as percentage collagen7SD as quanti¢ed by image analyzes.Values425% are signi¢cant (po0.05) from those found
with control vectors.
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ASuPAR. Strong thrombosis but little cellular in¢ltration was
induced by MMP-9, whereas the inhibitor TIMP-1was negative.
Several proteins induced thickening of the epidermis (acantho-
sis) (Fig 4C). The stimulation of epidermal cells was likely
mediated through indirect mechanisms, i.e., paracrine stimulation
of the epidermal cells by soluble factors released by the
transduced dermal cells (Liechty et al, 1999; Sylvester et al, 2000;
Berking et al, 2001a). There is little evidence of transduction of
epidermal cells (Berking et al, 2001a). bFGF, PDGF-B, SCF and
ET-3 most strongly induced thickening of the epidermis. The
mechanisms for epidermal stimulation are not clear. Dermal ¢-
broblasts can produce a variety of growth factors that can be mi-
togenic for keratinocytes and/or that inhibited di¡erentiation.
Factors includeTGF-a, KGF or ET (Ruiter et al, 2002). Epidermal
hyperplasia was also noted after injection of the chemokines IL-8
and MCP-1, apparently due to the release of keratinocyte mito-
gen by neutrophils and monocytic cells, respectively. Strong re-
sponses were seen for the ASuPAR adenoviral vector (Fig 4C).
It is plausible that disruption of the expression of the uPA recep-
tor (Mohan et al, 1999) activated keratinocyte mitogens in the ¢-
broblasts. The vector stimulated both epidermal thickness and
papillomatosis. On the other hand, neither uPA nor PAI-1 had
any e¡ects. Similar to ASuPAR, the growth factors SCF and
ET-3 stimulated the epidermal cells whereas the activities of
PDGF B,VEGF-D, and bFGF were weaker. The proto-oncogene
c-myc induced both epidermal hyperplasia and papillomatosis
Figure 2. Dynamics of changes in human skin after adenovirus vector-mediated overexpression of VEGF. Human foreskin xenograft injected
with recombinant adenovirus. (a) Xenograft before injection. (b^f) Same xenograft after intradermal injection of VEGF/Ad5 at 3 days (b), 7 days (c), 14 days
(d), 28 days (e), and 60 days (f). (g)Histological changes in human skin 3 days after VEGF/Ad5 injection. Edema and dilated vascular spaces are observed.
Endothelial cells are plump and bulge into the lumina (H&E staining,400). (h) Three days after LacZ/Ad5 injection, cellular in¢ltrate and edema are
limited (H&E,300).
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(not shown). The mechanisms for this stimulation are not clear.
The tumor suppressor gene p53 induced a response in the epider-
mal keratinocytes (not shown), but the mechanisms for this
stimulation are also not clear.
DISCUSSION
The human skin/SCID mouse chimera model is well suited for
studies of skin reorganization by growth factors, cytokines,
enzymes, inhibitors and a variety of other proteins or antagonists
associated with growth, di¡erentiation and transformation. The
advantage of the human skin/SCID mouse model is the mainte-
nance of normal skin architecture and the rapid response to
gene modulation. The disadvantages are the lack of an immune
response and potentially incomplete responses to murine cyto-
kines that do not bind or bind only weakly to the human recep-
tors of the skin grafts. All adenoviral vectors for growth factors
and cytokines used in this study expressed proteins that are
cross-reactive between mice and humans. On the other hand,
Figure 3. Staining of ¢xed sections of human skin grafts injected 3 days earlier with adenoviral vectors. (a) Human skin expressing lacZ stained
with trichrome for collagens, X50. (b) Human skin graft expressing uPA, H&E staining, X100. (c) Graft expressing uPA and stained with anticollagen type
IV antibodies to delineate vessel formation, X100.Vessel formation was seen similarly when sections were stained with anti-PECAM-1 (CD31) antibodies
(not shown). (d) Staining of grafts expressing lacZ using anticollagen type IV antibodies indicates few vessels. (e) Trichrome staining of human skin grafts
for all collagens after overexpression of IGF-1, X50. (f) IL-8 overexpression induced a strong neutrophilic in¢ltrate, H&E staining, X200. (g) MCP-1 -
induced macrophage in¢ltration, H&E staining, X200. (h) ASuPAR induced epidermal hyperplasia and papillomatosis, H&E staining, X100.
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in£ammatory molecules such as IL-1 or TNF-a are potentially
released by activated cells in the dermis and have no biological
e¡ects on the target cells because the human ligands may not
bind to the mouse receptors and vice versa.
The approach of intradermal injection was restricted to over-
expression in cells of the dermis because the human epidermis is
too thin for injection. Injection of the viral vectors in 100 mL of
bu¡er resulted in dissemination of the virus throughout the 1.5^2
cm2 grafts (Sylvester et al, 2000). The local elevation that was
created may have slightly separated the dermal matrix leading to
blister formation by the injected £uid, but healing occured very
quickly and did not cause any signi¢cant in£ammatory reaction.
Prior to infection with adenoviral vectors, in¢ltration of the
human skin by mouse cells was limited to endothelia and few
in£ammatory cells. Although the dermis contains both a human
and mouse vasculature (Yan et al, 1993), the mouse vasculature is
more activated by angiogenic growth factors, apparently due to
the continuous recruitment of endothelial cells from the
circulation (Asahara et al, 1999). Similarly, stimulation of ¢bro-
blasts with mitogens delivered by adenoviral gene transfer also
activated both human and mouse cells in the human skin grafts
(data not shown). Thus, despite a maintenance of the human
architecture after activation of skin for remodeling, the new cel-
lular components are of both mouse and human origins. This is
apparently due to the innate high activation state of mouse cells,
rapid migration of murine skin cells into the graft, and the hom-
ing of precursors of endothelial cells and ¢broblasts from the per-
ipheral blood and bone marrow.
The observation period of 3 d for histological evaluation was
relatively short and many processes of skin remodeling may
Figure 4. In£ammation and acanthosis 3 days after intradermal injection of adenoviral vectors for growth factors and proteolytic enzymes
into human skin grafts. (a) In¢ltration of in£ammatory cells into the dermis of adenoviral vector injection. Results are expressed as number of in£am-
matory cells including neutrophils and monocytic cells/mm27SD values4780 cells/mm2 are signi¢cant (po0.05). (b) Thrombosis of vessels in human skin
grafts, which was frequently associated with local necrosis. Results are expressed as number of thrombosed vessels/mm27SD. All values425 are signi¢cant
(po0.05). (c) Epidermal thickness after intradermal overexpression of growth factors and proteolytic enzymes. Results are expressed in mm thickness7SD
with all values40.16 mm being signi¢cant (po0.05).
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occur over longer time periods. However, adenovirus-mediated
gene transfer results in maximum protein expression after 72 h
and longer observation periods often resulted in the subsequent
activation of a battery of downstream targets, e.g., growth factors
and cytokines that obscure activity of the primary factor
(Berking et al, 2001a, 2001b; Nesbit et al, 2001a, 2001b). The 3-d
time point chosen re£ects best the activity of the transduced
growth factor gene.With the exception of bFGF and PDGF-B,
we have not seen qualitative changes at time points later than
day 3. bFGF does not have a signal sequence and induces in ¢bro-
blasts the expression of other growth factors that can have
secondary e¡ects. Similarly, secondary growth factors are induced
by PDGF-B. Total expression of the transgenes was limited to
approximately 2 wk due to the episomal nature of adenovirus-
mediated expression. On the other hand, cellular changes
continued to be visible for up to 8 wk as was demonstrated with
the adenoviral vector for VEGF. Milder changes may be reversed
shortly after cessation of adenovirus vector-mediated gene
expression.
The 38 vectors representing di¡erent gene factors showed three
groups of reactivities: (a) no response in any of the four main cri-
teria for characterization, which include increase in blood vessel
formation, ¢broblast proliferation with matrix formation,
in£ammatory cell in¢ltrate with thrombosis or necrosis, and
epidermal hyperplasia with papillomatosis; (b) strong response
for two or more criteria; and (c) one response (for a single criter-
ion). No changes were seen after overexpression of integrin sub-
units b3, a2, and a5, and of E- and N-cadherins.This is apparently
due to the con¢ned nature of gene expression in which the genes
cannot utilize their functions outside of the expressing cells and
the natural tissue context.
Overexpression of the oncogenes from human papilloma virus
type 16, E6 and E7 had no morphogenetic consequences because
dermal ¢broblasts in contrast to keratinocytes and melanocytes
are nonpermissive for the tumorigenic activity of these onco-
genes (Brandsma et al, 1995; Sexton et al, 1995). This suggested that
induced expression of the gene has to occur in the appropriate
tissue compartment. Single injections for gene overexpression
were insu⁄cient to cause signi¢cant remodeling in the three-d
period selected here for evaluation. However, even weekly injec-
tions for 12 wk of the E6 and E7 adenoviral vectors into the
human skin grafts together with thrice weekly irradiation of the
skin with ultraviolet light did not induce any signi¢cant
morphological changes (Berking et al, 2001a).While single injec-
tions of the adenoviral vector for bFGF as shown here induced
little changes, three injections induced strong angiogenesis and
stroma formation (Berking et al, 2001a). Thus, gene products that
are slowly released from cells for activation of the cellular envir-
onment may require repeated injections.
This study was not intended to investigate the mechanisms of
action for selected genes in skin disorders. An advantage of the
presented approach, however, is the discovery of genes with un-
expected reactivities. The most unpredicted result was the stimu-
latory activity of uPA for vessel formation. The enzyme can be
produced by all skin cells, including keratinocytes, melanocytes,
¢broblasts and endothelial cells. The mechanisms through which
it induced angiogenic responses are not clear. It appears to acti-
vate cell- or matrix-bound angiogenic factors. A chief example
is bFGF, which is bound to the extracellular matrix protein he-
paran sulfate proteoglycan (Vlodavsky et al, 1996; Tumova et al,
2000) and released through proteolytic cleavage.Whether the re-
lease of bFGF is critical or whether activation of additional fac-
tors is initiated awaits further studies. Another surprising result
occured when the receptor for uPAwas suppressed with an ade-
noviral antisense construct vector (Mohan et al, 1999). In this case,
a strong stimulation of the epidermis resulted through the inacti-
vation or activation of yet unde¢ned factors that stimulate
growth and prevent di¡erentiation of keratinocytes. Regarding
the apparent paradox as to the proin£ammatory e¡ects of both
uPA and PAI-1, the various e¡ects of the uPAR-uPA-PAI-1 sys-
tem depend on a complex interplay of intermolecular associations
and are subjected to ¢ne regulation. PAI-1 is a multifaceted pro-
teolytic factor (Blasi, 1997). It not only functions as an inhibitor
of uPA (with PAI-2), but also plays an important role in signal
transduction, cell adherence and cell migration. In addition to its
serpin activity as an inhibitor of receptor-bound uPA, PAI-1
prevents integrin avb3 asociation to vitronectin and appears to
regulate VEGF expression. Using adenovirus technology and
PAI-1-de¢cient mice, Bajou and colleagues showed that PAI-1
mutants (1) either bound vitronectin normally but failed to inhi-
bit uPA or (2) inhibited uPA normally but had negligible binding
to vitronectin (Bajou et al, 2001). In tumors, the concerted action
of uPA, uPAR and PAI-1 facilities invasion and metastasis (Blasi,
1997).While the cellular events associated with the wound heal-
ing process are similar between wild type and PAI-1/^ mice, the
rate of wound closure is signi¢cantly accelerated in PAI-1 /^
mice (Chan et al, 2001). More recently, Devy and colleagues
showed that the pro- or antiangiogenic e¡ect of PAI-1 is dose de-
pendent. These observations underscore the pleiotropic e¡ects of
PAI-1. Thus, PAI-1 may have various cellular and molecular ef-
fects that depend on a ¢nely tuned spatial and temporal expres-
sion, the net being an in£ammatory in¢ltrate in our model.
A variety of molecules for which a role in scleroderma has
been described (Kahaleh and Leroy, 1999), e.g.,TGF-b and PDGF,
cause a connective tissue reaction in our model, characterized by a
proliferation of ¢broblasts and matrix formation. This observa-
tion thus underscores the usefulness of the presented experimen-
tal approach for the study of this skin disorder. Another
unexpected ¢nding was the involvement of ET-3 in the vascular
response and the thickening of the epidermis (acanthosis). Both
are histopathologic hallmarks of psoriasis (Nickolo¡, 2000). A
third characteristic is leukocyte in¢ltration (Ortonne, 1999)
which was not in£uenced by ET-3 in our model. Nevertheless,
these observations make ET-3 an attractive, yet still speculative,
novel candidate for a pathogenetic role in psoriasis and psoriasi-
form tissue reactions.
In summary, our approach has shown the feasibility of the hu-
man skin/SCID mouse chimera model to investigate the activity
of individual genes for skin remodeling and dermatoses such as
psoriasis and scleroderma.This notion is in line with other obser-
vations (Nickolo¡, 2000). The con¢rmation of expected activities
for selected genes demonstrates that functions of unknown genes,
which may have biological signi¢cance for skin cells can be
discovered. Our studies then point to several genes that show
unexpected functions in skin reorganization and dermatological
disorders.
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